Related Experiment Video
Updated: Aug 14, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Three key residues underlie the differential affinity of the TGFbeta isoforms for the TGFbeta type II receptor
Gregory De Crescenzo1, Cynthia S Hinck, Zhanyong Shu
1Biotechnology Research Institute, National Research Council, Montreal, Que. Canada H4P2R2.
Abstract:
TGFbeta1, beta2, and beta3 are 25kDa homodimeric polypeptides that play crucial non-overlapping roles in development, tumor suppression, and wound healing. They exhibit 70-82% sequence identity and transduce their signals by binding and bringing together the TGFbeta type I and type II receptors, TbetaRI and TbetaRII. TGFbeta2 differs from the other isoforms in that it binds TbetaRII weakly and is dependent upon the co-receptor betaglycan for function. To explore the physicochemical basis underlying these differences, we generated a series of single amino acid TbetaRII variants based on the crystal structure of the TbetaRII:TGFbeta3 complex and examined these in terms of their TGFbeta isoform binding affinity and their equilibrium stability. The results showed that TbetaRII Ile53 and Glu119, which contact TGFbeta3 Val92 and Arg25, respectively, together with TbetaRII Asp32, Glu55, and Glu75, which contact TGFbeta3 Arg94, each contribute significantly, between 1 kcal mol(-1) to 1.5 kcal mol(-1), to ligand binding affinities. These contacts likely underlie the estimated 4.1 kcal mol(-1) lower affinity with which TbetaRII binds TGFbeta2 as these three ligand residues are unchanged in TGFbeta1 but are conservatively substituted in TGFbeta2 (Lys25, Ile92, and Lys94). To test this hypothesis, a TGFbeta2 variant was generated in which these three residues were changed to those in TGFbetas 1 and 3. This variant exhibited receptor binding affinities comparable to those of TGFbetas 1 and 3. Together, these results show that these three residues underlie the lowered affinity of TGFbeta2 for TbetaRII and that all isoforms likely induce assembly of the TGFbeta signaling receptors in the same overall manner.
Insights
Transforming growth factor-beta (TGFbeta) isoforms have distinct roles. Researchers identified three specific amino acid residues in TGFbeta receptor type II (TbetaRII) that explain TGFbeta2
Area of Science:
- Biochemistry
- Molecular Biology
- Cell Signaling
Background:
- Transforming growth factor-beta (TGFbeta) isoforms 1, 2, and 3 are critical signaling molecules with distinct functions in development, tumor suppression, and wound healing.
- These isoforms bind to TGFbeta type I and type II receptors (TbetaRI and TbetaRII) to transduce signals, but TGFbeta2 exhibits weaker binding to TbetaRII and relies on the co-receptor betaglycan.
- Understanding the molecular basis for these differential binding affinities is crucial for elucidating TGFbeta signaling pathways.
Purpose of the Study:
- To investigate the physicochemical basis for the differential binding affinities of TGFbeta isoforms to the TGFbeta receptor type II (TbetaRII).
- To identify specific amino acid residues in TbetaRII that contribute to ligand binding affinity and equilibrium stability for TGFbeta isoforms.
- To determine how specific amino acid substitutions in TGFbeta2 affect its binding affinity to TbetaRII.
Main Methods:
- Generation of single amino acid variants of TbetaRII based on the crystal structure of the TbetaRII:TGFbeta3 complex.
- Assays to measure TGFbeta isoform binding affinity to wild-type and variant TbetaRII.
- Analysis of equilibrium stability of TbetaRII variants in complex with TGFbeta isoforms.
Main Results:
- Specific TbetaRII residues (Ile53, Glu119, Asp32, Glu55, and Glu75) were identified as significant contributors to TGFbeta3 binding affinity.
- These contacts account for the weaker binding affinity of TbetaRII to TGFbeta2, attributed to conservative substitutions at ligand residues Lys25, Ile92, and Lys94 in TGFbeta2 compared to TGFbeta1 and TGFbeta3.
- A TGFbeta2 variant with residues mutated to match TGFbeta1 and TGFbeta3 exhibited comparable receptor binding affinities, confirming the role of these three residues.
Conclusions:
- Three specific amino acid residues in TGFbeta2 are responsible for its lower binding affinity to TbetaRII compared to TGFbeta1 and TGFbeta3.
- These identified residues and their interactions provide a molecular explanation for the differential binding of TGFbeta isoforms to their receptor.
- All TGFbeta isoforms likely assemble the TGFbeta signaling receptor complex in a similar overall manner, despite variations in initial binding affinity.
Related Concept Videos
TGF - β Signaling Pathway
The Two-State Receptor Model
The binding affinity of a drug determines its interaction with one...
Activation and Inactivation of G Proteins
Transducer Mechanism: G Protein–Coupled Receptors
GPCRs are also called heptahelical, 7TM, or...
Diversity of Antigen Receptors
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Receptor Tyrosine Kinases

